Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

686 public trials 116 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

NCT01670877

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • University of Alabama Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • University of Southern California Keck School of Medicine Los Angeles, California, United States
  • Stanford Medicine Cancer Institute Stanford, California, United States
View all 17 locations
View Trial Details
Completed

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

NCT01945775

Conditions
BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Diseases, +5 more
Locations
  • Arizona Oncology Associates P.C. - NAHOA Flagstaff, Arizona, United States
  • HonorHealth Scottsdale, Arizona, United States
  • Virginia G. Piper Cancer Pharmacy Scottsdale, Arizona, United States
  • Kaiser Permanente Medical Center Lab Drawing Station Antioch, California, United States
View all 362 locations
View Trial Details
Completed

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

NCT03556358

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Tanvex Investigational Site 1008 Lyasny, Minsk Oblast, Belarus
  • Tanvex Investigational Site 1007 Babruysk, Mogilyov Oblast, Belarus
  • Tanvex Investigational Site 1006 Grodno, Belarus
  • Tanvex Investigational Site 1003 Homyel, Belarus
View all 146 locations
View Trial Details

Related conditions